Pfizer's Jeffrey Kindler - CEO Pay
Jeffrey Kindler - Pfizer 
Total Compensation: $12.6M
2007 Revenue: $48.6B
2006 Revenue: $48.3B
Change: .6%
Details: 2007 was not Pfizer's best year, seeing that the company started things off with one of the biggest drug development flops in recent history. CEO Jeffrey Kindler's pay is low when compared to rivals, but it was still up significantly from $9.8 million in 2006. Kindler pulled in $1.35 million in base pay, $3.1 million in cash bonuses (down slightly from 2006), $7.5 million in stock and options. His other compensation included $175,000 for aircraft use and over $42,000 for his use of a car.
Pfizer News:
Woe is Pfizer, analysts say
Investors, analysts not impressed with Pfizer
Is Pfizer's CEO as bold as promised?
Pfizer chiefs sees pay decline
Pfizer's Kindler leaves analysts feeling flat
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
